TY  - JOUR
AU  - Fernandez-Mateos, J.
AU  - Seijas-Tamayo, R.
AU  - Mesia, R.
AU  - Taberna, M.
AU  - Pastor Borgonon, M.
AU  - Perez-Ruiz, E.
AU  - Klain, J. C. Adansa
AU  - Vazquez Fernandez, S.
AU  - del Barco Morillo, E.
AU  - Lozano, A.
AU  - Gonzalez Sarmiento, R.
AU  - Cruz-Hernandez, J. J.
AU  - Spanish Head Neck Canc Cooperative
PY  - 2016
DO  - 10.1016/j.oraloncology.2016.10.006
SN  - 1368-8375
UR  - https://hdl.handle.net/10668/26658
T2  - Oral oncology
AB  - Objectives: To examine the relationship between polymorphisms of the epidermal growth factor receptor (EGFR) pathway and toxicity in head and neck squamous cell carcinoma (HNSCC) patients treated with cetuximab.Material and methods: Multicenter,...
LA  - en
PB  - Elsevier science bv
KW  - Head and neck squamous cell carcinoma (HNSCC)
KW  - Epidermal growth factor receptor (EGFR)
KW  - Polymorphism
KW  - SNP
KW  - EGFR
KW  - CCDN1
KW  - FCGR2A
KW  - FCGR3A
KW  - KRAS-LCS6
KW  - Cetuximab
KW  - Toxicity
KW  - Platinum-based chemotherapy
KW  - Phase-ii
KW  - Plus cetuximab
KW  - Skin toxicity
KW  - Single-agent
KW  - Lung-cancer
KW  - Open-label
KW  - Risk
KW  - Epidemiology
KW  - Combination
TI  - Epidermal growth factor receptor (EGFR) pathway polymorphisms as predictive markers of cetuximab toxicity in locally advanced head and neck squamous cell carcinoma (HNSCC) in a Spanish population
TY  - research article
VL  - 63
ER  -